UBS Group AG - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,675,435
-48.3%
285,532
+35.4%
0.00%
-50.0%
Q2 2023$5,171,611
+82.0%
210,828
+72.6%
0.00%
+100.0%
Q1 2023$2,841,872
-61.2%
122,126
-57.8%
0.00%
-66.7%
Q4 2022$7,332,991
+263.9%
289,727
+177.2%
0.00%
+200.0%
Q3 2022$2,015,000
-37.6%
104,528
-17.6%
0.00%0.0%
Q2 2022$3,231,000
-60.9%
126,875
-60.5%
0.00%
-66.7%
Q1 2022$8,258,000
+106.0%
321,053
+235.5%
0.00%
+200.0%
Q4 2021$4,008,000
+353.4%
95,707
+370.7%
0.00%
Q3 2021$884,000
-14.2%
20,332
-6.7%
0.00%
Q2 2021$1,030,000
-42.6%
21,791
-37.7%
0.00%
-100.0%
Q1 2021$1,793,000
+47.2%
34,976
-23.1%
0.00%
Q4 2020$1,218,000
-45.8%
45,491
-30.5%
0.00%
-100.0%
Q3 2020$2,246,000
+46.5%
65,421
+74.8%
0.00%0.0%
Q2 2020$1,533,000
+972.0%
37,428
+793.9%
0.00%
Q1 2020$143,000
-4.7%
4,187
-65.0%
0.00%
Q4 2019$150,00011,9570.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders